	Genomic drivers of brain metastases in lung cancer. Neurooncol Adv Wang T, Xing H, Huang L, Zhuang H, Zhang J, Ge H, Zhang B, Cao Y, Zhai Y, Zheng X, Bu S, Abbas AE, Hadfield M, Carneiro BA, Cheng L, Liu Y. PMID: 42359386 [PubMed - in process]
	Engineering the Future of ADCs in Non-Small Cell Lung Cancer. Oncol Res Kim MR, Lau J, Maffezzoli M, Banna GL. PMID: 42358829 [PubMed - in process]
	Integrative Analysis of Glycosylation-Related Genes Reveals Prognostic Subtypes, Immune Evasion, and Therapeutic Vulnerabilities in Lung Adenocarcinoma. Oncol Res Liu YW, Lee YK, Chang KF, Hsieh CB, Chang CH, Ko CC, Lin HR, Wu CJ, Yuan CH, Kumar S, Solomon DD, Xuan DTM, Palekkode N, Fathima A, Lin HY, Wang CY, Yang CJ, Wu YJ. PMID: 42358820 [PubMed - in process]
	Occult Pulmonary Adenosquamous Carcinoma Presenting With Synchronous Colonic Metastases. Am Surg Hyche MH, Lopez I, Schammel CM, Devane AM, Schammel DP, Yurko YY. PMID: 42357822 [PubMed - as supplied by publisher]
	Prognostic Significance of Preoperative PET-CT SUVmax in Resected Non-Small Cell Lung Cancer: A Single-Center Retrospective Study. Medicina (Kaunas) Ya, Ya, Y, Do, Kaya T, Aydo, Ba, I, Odaba, Turan N. PMID: 42356017 [PubMed - in process]
	Real-World Outcomes of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small-Cell Lung Cancer: A Retrospective Single-Center Study. J Clin Med Koren E, Yaacov A, Zidan J, C Roisman L, Peled N, Asna N. PMID: 42355925 [PubMed - in process]
	A Cross-Sectional Study of Large Language Models in Lung Cancer Information Delivery: Readability, Quality, and Patient-Centred Evaluation. Healthcare (Basel) Önal Ö, Bekce ST. PMID: 42354626 [PubMed - in process]
	The Predictive Role of ctDNA and CTCs in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy: A Systematic Review and Meta-Analysis. Int J Mol Sci Kakouri AC, Spiliotaki M, Deltas C, Papagregoriou G, Charalambous H. PMID: 42353230 [PubMed - in process]
	A Multi-Level miRNA Regulatory Network Associated with IRF1 Expression in Non-Small Cell Lung Cancer: In Silico Identification of Candidate Biomarkers for Immunotherapy Response. Int J Mol Sci Karaseva DV, Perevalova AM, Kalinina TS, Kononchuk VV, Kozlov VV, Gulyaeva LF, Pustylnyak VO. PMID: 42352916 [PubMed - in process]
	Artificial Intelligence and the Evolving Paradigm of Lung Cancer Management. Cancers (Basel) Martins RS, Hanna Y, Axtell AL. PMID: 42352544 [PubMed - in process]
	Pre- or Perioperative Immunotherapy Combined with Chemotherapy Versus Chemotherapy Alone in Resectable Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review. Cancers (Basel) Lehner S, Singer J, Hackner K, Armster K, Dietl W, Ghanim B. PMID: 42352534 [PubMed - in process]
	Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study. Cancers (Basel) Köylü B, Celayir ÖM, Mu, Can O, , Öven BB, Demirci U, , Karakaya S, Er Ö, Ekinci ÖB, Sakin A, Gür HB, Karaman Y, Ercan Uzundal D, A, Pilanc, Avc, Gürsoy P, Kaplan MA, Menek, Kut E, Arpac, Kosku H, Bayram S, , Türkmen E, Aykut A, A, Özveren A, , Ate, Serin Özel G, K, Kemik F, Oyan B, Korkmaz T, Demir OG, Tural D, Gündüz , Laçin , Demir N, Tunal, Bilici A, Ölmez ÖF, Hac, Çubukçu E, Yaz, Y, Bilgin B, , Tatl, Özdo, Akta, Kan, Karabulut B, Ekinci F, Bayram E, Gököz Do, K, Yumuk PF, Molinas Mandel N, Selçukbiricik F. PMID: 42352512 [PubMed - in process]
	Prophylactic Cranial Irradiation in MRI-Staged Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Survival and Neurocognitive Outcomes. Cancers (Basel) Li S, Zheng X, Meng Y, Chen G, Zhao C, Zhong S, Li H, Bai R, Dong Y, Kong FS. PMID: 42352503 [PubMed - in process]
	Microbial Influence on Immune Checkpoint Inhibitor Therapy in Non-Small Cell Carcinoma: The Gut-Lung-Immune Axis. Cancers (Basel) Ali H, Xie B, Yang J, Nadeem U. PMID: 42352482 [PubMed - in process]
	Intraoperative Nodule Localization in Non-Small-Cell Lung Cancer: Existing and Emerging Techniques. Cancers (Basel) Aicher A, Tidwell J, Singhal S, Predina J. PMID: 42352449 [PubMed - in process]
	CT-Derived Radiomic Features for the Non-Invasive Differentiation of Mediastinal Lymphadenopathy in Lung Cancer and Sarcoidosis. Biomedicines Do, Öksüz C, Çak, Güllü Z, Urhan O. PMID: 42351755 [PubMed - in process]
	Identification of Novel Protein Biomarkers for Early Detection of Radon-Induced Lung Cancer: A Comparative Study in Kazakhstan. Biomedicines Kazhiyakhmetova B, Altaeva N, Bakhtin M, Tarlykov P, Omori Y, Tokonami S, Kranrod C, Pradana R, Musikawan S, Lesbek A, Ibrayeva D, Saifulina E, Auganova D, Aumalikova M, Kairullova M, Shokabayeva A, Bizhanova D, Kashkinbayev Y. PMID: 42351632 [PubMed - in process]
	Feature Selection and Machine Learning Strategies for CT Radiomics-Based Survival Prediction in Non-Small Cell Lung Cancer: A Comparative Study. Diagnostics (Basel) Huang M, Hui A, Leung CW, Li CL, Leung TL, Tang FH, Tam SY. PMID: 42351421 [PubMed - in process]
	Microbiome-host interactions in different pathomic subtypes of early-stage lung adenocarcinoma. BMC Pulm Med He T, Ai Z, Han Q, Chen F, Wang H, Wu M, Chen Q, Li S, Wang L, Yang Z, Wang P, Wang Z, Xiang Z. PMID: 42351035 [PubMed - as supplied by publisher]
	Pathogen distribution characteristics and risk factors of pulmonary infection associated with immune checkpoint inhibitor therapy in patients with advanced non-small cell lung cancer: a case control study. BMC Infect Dis Tian R, Cui X, Wang L, Yan L, Wang P. PMID: 42350998 [PubMed - as supplied by publisher]

Articles 1 - 20 / 160770

Page 1 of 8039



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy